Sage Journals: Discover world-class research

Open access

Case report

First published 2022

Critically ill patients with edema and ascites may experience subtherapeutic anti-factor Xa levels following abdominal subcutaneous enoxaparin treatment

Vichapat Tharanon, Theerasuk Kawamatawong

Sage Open Medical Case Reports

Retricted access

Research article

First published 2019-8

Comparing Anti–Factor Xa and Activated Partial Thromboplastin Levels for Monitoring Unfractionated Heparin

Rebekah A. Wahking, Rachel H. Hargreaves, Sean M. Lockwood [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2021

Safety and Efficacy of Prophylactic Enoxaparin Adjusted by Anti-Factor Xa Peak Levels in Pancreatic Surgery

Katherine Kramme, Paya Sarraf, Saad Shebrain [...]

The American Surgeon™

Retricted access

Research article

First published 2022-12

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

Scott J. Dingus, Alex R. Smith, William E. Dager [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2024-4

Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin

Shane A. Sheredy, Andrew C. Stone, Ahmad M. Mostafavifar [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2020

Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study

Hakeam A. Hakeam, Zainab Al Duhailib, Muhannad Alsemari [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2015-12

Adjusted-Dose Enoxaparin for VTE Prevention in the Morbidly Obese

Saumeel Parikh, Bernadette Jakeman, Erin Walsh [...]

Journal of Pharmacy Technology

Retricted access

Brief report

First published 2024-6

Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study

Samuel Coster, Ali Shammout, Michael Chaney [...]

The American Surgeon™

Retricted access

Letter

First published 2025-1

Letter re: Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study

Stephanie S. Hyon, Jana K. Elsawwah, Maia A. Harris [...]

The American Surgeon™

Retricted access

Research article

First published 2022-12

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie C. Ruegger, Eric Salazar [...]

Journal of Pharmacy Practice

Search results